IBDEI1T2 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30224,0)
 ;;=Z83.511^^135^1373^30
 ;;^UTILITY(U,$J,358.3,30224,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30224,1,3,0)
 ;;=3^Family Hx of Glaucoma
 ;;^UTILITY(U,$J,358.3,30224,1,4,0)
 ;;=4^Z83.511
 ;;^UTILITY(U,$J,358.3,30224,2)
 ;;=^5063382
 ;;^UTILITY(U,$J,358.3,30225,0)
 ;;=Z80.52^^135^1373^33
 ;;^UTILITY(U,$J,358.3,30225,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30225,1,3,0)
 ;;=3^Family Hx of Malig Neop of Baldder
 ;;^UTILITY(U,$J,358.3,30225,1,4,0)
 ;;=4^Z80.52
 ;;^UTILITY(U,$J,358.3,30225,2)
 ;;=^5063352
 ;;^UTILITY(U,$J,358.3,30226,0)
 ;;=Z80.51^^135^1373^36
 ;;^UTILITY(U,$J,358.3,30226,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30226,1,3,0)
 ;;=3^Family Hx of Malig Neop of Kidney
 ;;^UTILITY(U,$J,358.3,30226,1,4,0)
 ;;=4^Z80.51
 ;;^UTILITY(U,$J,358.3,30226,2)
 ;;=^321159
 ;;^UTILITY(U,$J,358.3,30227,0)
 ;;=Z83.41^^135^1373^43
 ;;^UTILITY(U,$J,358.3,30227,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30227,1,3,0)
 ;;=3^Family Hx of Mult Endocrine Neoplasia Syndrome
 ;;^UTILITY(U,$J,358.3,30227,1,4,0)
 ;;=4^Z83.41
 ;;^UTILITY(U,$J,358.3,30227,2)
 ;;=^5063380
 ;;^UTILITY(U,$J,358.3,30228,0)
 ;;=Z81.8^^135^1373^50
 ;;^UTILITY(U,$J,358.3,30228,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30228,1,3,0)
 ;;=3^Family Hx of Substance Abuse/Dependence,Psychoactive
 ;;^UTILITY(U,$J,358.3,30228,1,4,0)
 ;;=4^Z81.8
 ;;^UTILITY(U,$J,358.3,30228,2)
 ;;=^5063363
 ;;^UTILITY(U,$J,358.3,30229,0)
 ;;=Z81.4^^135^1373^51
 ;;^UTILITY(U,$J,358.3,30229,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30229,1,3,0)
 ;;=3^Family Hx of Substance Abuse/Dependence NEC
 ;;^UTILITY(U,$J,358.3,30229,1,4,0)
 ;;=4^Z81.4
 ;;^UTILITY(U,$J,358.3,30229,2)
 ;;=^5063362
 ;;^UTILITY(U,$J,358.3,30230,0)
 ;;=Z98.0^^135^1373^62
 ;;^UTILITY(U,$J,358.3,30230,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30230,1,3,0)
 ;;=3^Intestinal Bypass/Anastomosis Status
 ;;^UTILITY(U,$J,358.3,30230,1,4,0)
 ;;=4^Z98.0
 ;;^UTILITY(U,$J,358.3,30230,2)
 ;;=^5063733
 ;;^UTILITY(U,$J,358.3,30231,0)
 ;;=Z91.128^^135^1373^61
 ;;^UTILITY(U,$J,358.3,30231,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30231,1,3,0)
 ;;=3^Intentional Underdose of Meds d/t Other Reasons
 ;;^UTILITY(U,$J,358.3,30231,1,4,0)
 ;;=4^Z91.128
 ;;^UTILITY(U,$J,358.3,30231,2)
 ;;=^5063613
 ;;^UTILITY(U,$J,358.3,30232,0)
 ;;=Z77.120^^135^1373^67
 ;;^UTILITY(U,$J,358.3,30232,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30232,1,3,0)
 ;;=3^Mold (Toxic) Contact/Exposure
 ;;^UTILITY(U,$J,358.3,30232,1,4,0)
 ;;=4^Z77.120
 ;;^UTILITY(U,$J,358.3,30232,2)
 ;;=^5063318
 ;;^UTILITY(U,$J,358.3,30233,0)
 ;;=Z86.74^^135^1373^110
 ;;^UTILITY(U,$J,358.3,30233,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30233,1,3,0)
 ;;=3^Personal Hx of Sudden Cardiac Arrest 
 ;;^UTILITY(U,$J,358.3,30233,1,4,0)
 ;;=4^Z86.74
 ;;^UTILITY(U,$J,358.3,30233,2)
 ;;=^5063478
 ;;^UTILITY(U,$J,358.3,30234,0)
 ;;=Z86.718^^135^1373^117
 ;;^UTILITY(U,$J,358.3,30234,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30234,1,3,0)
 ;;=3^Personal Hx of Venous Thrombosis/Embolism (DVT)
 ;;^UTILITY(U,$J,358.3,30234,1,4,0)
 ;;=4^Z86.718
 ;;^UTILITY(U,$J,358.3,30234,2)
 ;;=^5063475
 ;;^UTILITY(U,$J,358.3,30235,0)
 ;;=Z96.1^^135^1373^127
 ;;^UTILITY(U,$J,358.3,30235,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30235,1,3,0)
 ;;=3^Presence of Intraocular Lens
 ;;^UTILITY(U,$J,358.3,30235,1,4,0)
 ;;=4^Z96.1
 ;;^UTILITY(U,$J,358.3,30235,2)
 ;;=^5063682
 ;;^UTILITY(U,$J,358.3,30236,0)
 ;;=Z96.612^^135^1373^132
 ;;^UTILITY(U,$J,358.3,30236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30236,1,3,0)
 ;;=3^Presence of Left Artificial Shoulder Joint
